(PBA) Pembina Pipeline - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA7063271034
Stock:
Total Rating 52
Risk 68
Buy Signal 0.42
| Risk 5d forecast | |
|---|---|
| Volatility | 18.0% |
| Relative Tail Risk | -2.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 22.80 |
| Character TTM | |
|---|---|
| Beta | 0.236 |
| Beta Downside | 0.781 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.92% |
| CAGR/Max DD | 0.89 |
EPS (Earnings per Share)
Revenue
Description: PBA Pembina Pipeline
Pembina Pipeline Corporation provides energy transportation and midstream services. It operates through three segments: Pipelines, Facilities, Marketing & New Ventures, and Corporate and Income Tax. The Pipelines segment operates conventional, oil sands and heavy oil, and transmission assets with a transportation capacity of 3.0 million of barrels of oil equivalent per day, the ground storage capacity of 10 million of barrels, and rail terminalling capacity of approximately 105 thousands of barrels of oil equivalent per day serving markets and basins across North America. The Facilities segment offers infrastructure that provides customers with crude oil, natural gas, condensate, and natural gas liquids (NGLs), including ethane, propane, butane, and condensate; and includes 430 thousands of barrels of NGL fractionation capacity, 21 million of barrels of cavern storage capacity, and various oil batteries, associated pipeline, and rail terminalling facilities and a liquefied propane export facility. The Marketing & New Ventures segment buys and sells hydrocarbon liquids and natural gas originating in the Western Canadian sedimentary basin and other basins. Pembina Pipeline Corporation was incorporated in 1954 and is headquartered in Calgary, Canada.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.69b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.39 > 1.0 |
| NWC/Revenue: -10.32% < 20% (prev -17.72%; Δ 7.39% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.04b > Net Income 1.69b |
| Net Debt (13.20b) to EBITDA (3.63b): 3.64 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (582.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 39.55% > 18% (prev 0.44%; Δ 3911 % > 0.5%) |
| Asset Turnover: 21.83% > 50% (prev 20.95%; Δ 0.88% > 0%) |
| Interest Coverage Ratio: 4.40 > 6 (EBITDA TTM 3.63b / Interest Expense TTM 604.9m) |
Altman Z'' 1.07
| A: -0.02 (Total Current Assets 1.26b - Total Current Liabilities 2.06b) / Total Assets 35.55b |
| B: -0.07 (Retained Earnings -2.43b / Total Assets 35.55b) |
| C: 0.07 (EBIT TTM 2.66b / Avg Total Assets 35.76b) |
| D: 0.89 (Book Value of Equity 16.77b / Total Liabilities 18.78b) |
| Altman-Z'' Score: 1.07 = BB |
Beneish M -3.13
| DSRI: 0.74 (Receivables 836.0m/1.08b, Revenue 7.81b/7.54b) |
| GMI: 1.11 (GM 39.55% / 44.01%) |
| AQI: 1.02 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.04 (Revenue 7.81b / 7.54b) |
| TATA: -0.04 (NI 1.69b - CFO 3.04b) / TA 35.55b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of PBA shares?
As of March 03, 2026, the stock is trading at USD 44.99 with a total of 1,431,684 shares traded.
Over the past week, the price has changed by +2.00%, over one month by +9.79%, over three months by +18.28% and over the past year by +23.13%.
Over the past week, the price has changed by +2.00%, over one month by +9.79%, over three months by +18.28% and over the past year by +23.13%.
Is PBA a buy, sell or hold?
Pembina Pipeline has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy PBA.
- StrongBuy: 8
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PBA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | -9% |
| Analysts Target Price | 41 | -9% |
PBA Fundamental Data Overview March 03, 2026
P/E Trailing = 21.4585
P/E Forward = 21.2766
P/S = 3.2856
P/B = 2.3232
P/EG = 2.3484
Revenue TTM = 7.81b USD
EBIT TTM = 2.66b USD
EBITDA TTM = 3.63b USD
Long Term Debt = 11.54b USD (from longTermDebt, two quarters ago)
Short Term Debt = 683.0m USD (from shortTermDebt, last quarter)
Debt = 13.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.20b USD (from netDebt column, last quarter)
Enterprise Value = 38.76b USD (25.56b + Debt 13.31b - CCE 106.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 2.66b / Interest Expense TTM 604.9m)
EV/FCF = 16.90x (Enterprise Value 38.76b / FCF TTM 2.29b)
FCF Yield = 5.92% (FCF TTM 2.29b / Enterprise Value 38.76b)
FCF Margin = 29.37% (FCF TTM 2.29b / Revenue TTM 7.81b)
Net Margin = 21.70% (Net Income TTM 1.69b / Revenue TTM 7.81b)
Gross Margin = 39.55% ((Revenue TTM 7.81b - Cost of Revenue TTM 4.72b) / Revenue TTM)
Gross Margin QoQ = 34.29% (prev 40.42%)
Tobins Q-Ratio = 1.09 (Enterprise Value 38.76b / Total Assets 35.55b)
Interest Expense / Debt = 1.09% (Interest Expense 144.9m / Debt 13.31b)
Taxrate = 23.23% (148.0m / 637.0m)
NOPAT = 2.04b (EBIT 2.66b * (1 - 23.23%))
Current Ratio = 0.61 (Total Current Assets 1.26b / Total Current Liabilities 2.06b)
Debt / Equity = 0.79 (Debt 13.31b / totalStockholderEquity, last quarter 16.77b)
Debt / EBITDA = 3.64 (Net Debt 13.20b / EBITDA 3.63b)
Debt / FCF = 5.76 (Net Debt 13.20b / FCF TTM 2.29b)
Total Stockholder Equity = 17.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.74% (Net Income 1.69b / Total Assets 35.55b)
RoE = 9.91% (Net Income TTM 1.69b / Total Stockholder Equity 17.10b)
RoCE = 9.30% (EBIT 2.66b / Capital Employed (Equity 17.10b + L.T.Debt 11.54b))
RoIC = 7.35% (NOPAT 2.04b / Invested Capital 27.80b)
WACC = 4.74% (E(25.56b)/V(38.87b) * Re(6.78%) + D(13.31b)/V(38.87b) * Rd(1.09%) * (1-Tc(0.23)))
Discount Rate = 6.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 2.87%
[DCF] Terminal Value 87.17% ; FCFF base≈2.10b ; Y1≈2.30b ; Y5≈2.90b
[DCF] Fair Price = 124.8 (EV 85.69b - Net Debt 13.20b = Equity 72.49b / Shares 580.9m; r=5.90% [WACC]; 5y FCF grow 10.49% → 2.90% )
EPS Correlation: -22.95 | EPS CAGR: -1.83% | SUE: 1.22 | # QB: 1
Revenue Correlation: -55.14 | Revenue CAGR: -12.25% | SUE: -0.42 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.73 | Chg7d=+0.033 | Chg30d=+0.033 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.79 | Chg7d=-0.037 | Chg30d=-0.063 | Revisions Net=-1 | Growth EPS=+8.4% | Growth Revenue=-4.5%
EPS next Year (2027-12-31): EPS=3.10 | Chg7d=+0.029 | Chg30d=+0.005 | Revisions Net=-3 | Growth EPS=+11.1% | Growth Revenue=+18.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = -3.5% (Analyst -0.2% - Implied 3.3%)
P/E Forward = 21.2766
P/S = 3.2856
P/B = 2.3232
P/EG = 2.3484
Revenue TTM = 7.81b USD
EBIT TTM = 2.66b USD
EBITDA TTM = 3.63b USD
Long Term Debt = 11.54b USD (from longTermDebt, two quarters ago)
Short Term Debt = 683.0m USD (from shortTermDebt, last quarter)
Debt = 13.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.20b USD (from netDebt column, last quarter)
Enterprise Value = 38.76b USD (25.56b + Debt 13.31b - CCE 106.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 2.66b / Interest Expense TTM 604.9m)
EV/FCF = 16.90x (Enterprise Value 38.76b / FCF TTM 2.29b)
FCF Yield = 5.92% (FCF TTM 2.29b / Enterprise Value 38.76b)
FCF Margin = 29.37% (FCF TTM 2.29b / Revenue TTM 7.81b)
Net Margin = 21.70% (Net Income TTM 1.69b / Revenue TTM 7.81b)
Gross Margin = 39.55% ((Revenue TTM 7.81b - Cost of Revenue TTM 4.72b) / Revenue TTM)
Gross Margin QoQ = 34.29% (prev 40.42%)
Tobins Q-Ratio = 1.09 (Enterprise Value 38.76b / Total Assets 35.55b)
Interest Expense / Debt = 1.09% (Interest Expense 144.9m / Debt 13.31b)
Taxrate = 23.23% (148.0m / 637.0m)
NOPAT = 2.04b (EBIT 2.66b * (1 - 23.23%))
Current Ratio = 0.61 (Total Current Assets 1.26b / Total Current Liabilities 2.06b)
Debt / Equity = 0.79 (Debt 13.31b / totalStockholderEquity, last quarter 16.77b)
Debt / EBITDA = 3.64 (Net Debt 13.20b / EBITDA 3.63b)
Debt / FCF = 5.76 (Net Debt 13.20b / FCF TTM 2.29b)
Total Stockholder Equity = 17.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.74% (Net Income 1.69b / Total Assets 35.55b)
RoE = 9.91% (Net Income TTM 1.69b / Total Stockholder Equity 17.10b)
RoCE = 9.30% (EBIT 2.66b / Capital Employed (Equity 17.10b + L.T.Debt 11.54b))
RoIC = 7.35% (NOPAT 2.04b / Invested Capital 27.80b)
WACC = 4.74% (E(25.56b)/V(38.87b) * Re(6.78%) + D(13.31b)/V(38.87b) * Rd(1.09%) * (1-Tc(0.23)))
Discount Rate = 6.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 2.87%
[DCF] Terminal Value 87.17% ; FCFF base≈2.10b ; Y1≈2.30b ; Y5≈2.90b
[DCF] Fair Price = 124.8 (EV 85.69b - Net Debt 13.20b = Equity 72.49b / Shares 580.9m; r=5.90% [WACC]; 5y FCF grow 10.49% → 2.90% )
EPS Correlation: -22.95 | EPS CAGR: -1.83% | SUE: 1.22 | # QB: 1
Revenue Correlation: -55.14 | Revenue CAGR: -12.25% | SUE: -0.42 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.73 | Chg7d=+0.033 | Chg30d=+0.033 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.79 | Chg7d=-0.037 | Chg30d=-0.063 | Revisions Net=-1 | Growth EPS=+8.4% | Growth Revenue=-4.5%
EPS next Year (2027-12-31): EPS=3.10 | Chg7d=+0.029 | Chg30d=+0.005 | Revisions Net=-3 | Growth EPS=+11.1% | Growth Revenue=+18.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = -3.5% (Analyst -0.2% - Implied 3.3%)